Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Close this folderIV. Preliminary findings
Open this folder and view contents1. The methods: What has been learnt?
Open this folder and view contents2. National drug policies: what has been learnt?
Close this folder3. Cross national analysis: What can be learnt at this stage?
View the document3.1 Relevance of the methods for cross national comparison
View the document3.2 Strengths and weaknesses of NDP from a cross national perspective
View the document3.3 Tentative explanations for cross national variations
View the document4. Broader capacity building
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series
 

3. Cross national analysis: What can be learnt at this stage?

During the last session of the workshop the participants reviewed what could be learnt from the comparative nature of the research. They tried to achieve the following:

• discuss the extent to which the methodologies successfully accomplished this cross national comparison;

• identify and substantiate strengths and weaknesses of existing policy from cross national perspectives;

• propose explanations for cross national variations in performance; and

• identify specific policy innovations from cross national learning that can improve the implementation of pharmaceutical policies.

The conclusions presented below are preliminary and need further analysis.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014